Loading company details...
Beta
Latest Form 4 (Jun 3, 2025): Fortress Biotech, Inc. (10% Owner): Sale of 100,000 shares, $129.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2025 | Fortress Biotech, Inc. | Sale | 100,000 | $129.0K |
| Feb 27, 2025 | Fortress Biotech, Inc. | Grant/Award | 18,500 | n/a |
| Jan 3, 2025 | Fortress Biotech, Inc. | Grant/Award | 81,407 | n/a |
| Oct 1, 2024 | Fortress Biotech, Inc. | Grant/Award | 146,341 | n/a |
| Jun 28, 2024 | James F. Oliviero III, CEO, President and Director | Sale | 24,610 | $50.5K |
| Jun 28, 2024 | William Garrett Gray, Chief Financial Officer | Sale | 13,038 | $26.9K |
| May 24, 2024 | William Garrett Gray, Chief Financial Officer | Grant/Award | 540,000 | n/a |
| May 24, 2024 | James F. Oliviero III, CEO, President and Director | Grant/Award | 1,660,000 | n/a |
| May 16, 2024 | Michael S. Weiss | Grant/Award | 32,051 | n/a |
| May 16, 2024 | Sharma Amit | Grant/Award | 32,051 | n/a |